NO16 NEUROONE LOGO_RGB.png
NeuroOne® Announces Breakthrough Case Completed with OneRF™ Ablation System at the University Hospitals in Cleveland
September 10, 2024 09:00 ET | NeuroOne Medical Technologies Corp
Forty-four ablations performed successfully in one patient Patient currently reportedly seizure free with improvements in mood and memory EDEN PRAIRIE, Minn., Sept. 10, 2024 (GLOBE NEWSWIRE)...
NO16 NEUROONE LOGO_RGB.png
NeuroOne® Announces First in Human Ablations Completed with OneRF™ Ablation System
June 25, 2024 09:00 ET | NeuroOne Medical Technologies Corp
Five ablations performed successfully in one patient Procedure performed at patient’s bedside saving time and cost associated with the operating room EDEN PRAIRIE, Minn., June 25, 2024 (GLOBE...
NO16 NEUROONE LOGO_RGB.png
NeuroOne® Receives FDA 510(k) Clearance to Market its OneRF™ Ablation System
December 11, 2023 08:00 ET | NeuroOne Medical Technologies Corp
First FDA-cleared thin-film, sEEG-guided RF system capable of both recording electrical activity and ablating nervous tissue with the added benefit of temperature control; Marks the Company’s third...
NO16 NEUROONE LOGO_RGB.png
NeuroOne Medical Technologies Corporation Announces Pricing of Public Offering of Common Stock
July 25, 2023 08:00 ET | NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., July 25, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (the “Company”), a medical technology company focused on improving surgical care...